McCarthy B G, Hsieh S T, Stocks A, Hauer P, Macko C, Cornblath D R, Griffin J W, McArthur J C
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Neurology. 1995 Oct;45(10):1848-55. doi: 10.1212/wnl.45.10.1848.
To use punch skin biopsies to evaluate the loss of intra-epidermal nerve fibers in sensory neuropathies.
Previous assessments of epidermal nerve fibers have been constrained by relatively insensitive staining techniques and variability in quantification.
Punch skin biopsies were performed on the heel and leg of HIV-seronegative controls, HIV-seropositive individuals without neuropathy, and patients with sensory neuropathies, including HIV-seronegative and HIV-positive individuals. After formalin fixation, 50-microns free-floating sections were stained with a monoclonal antibody to neuron-specific ubiquitin hydrolase, PGP9.5. The number of intraepidermal fibers/mm in at least three sections from each patient was counted by one observer blinded to site and clinical status.
Dermal and epidermal nerve fibers were readily identified and quantified. The immunostaining technique reliably demonstrated a dermal plexus of myelinated and unmyelinated fibers parallel to the surface of the skin. In the epidermis, unmyelinated fibers ascended vertically between the keratinocytes to reach the stratum corneum. The number of intra-epidermal fibers/mm in the distal leg (mean +/- SEM) was 17.84 +/- 3.03 in seven HIV-seronegative controls. Epidermal fiber number was significantly reduced (p = 0.01) in five HIV-infected patients with sensory neuropathies associated with didanosine or zalcitabine therapy (1.07 +/- 0.40) and in eight HIV-seronegative patients with sensory neuropathies (3.1 +/- 3.1). Four of five neurologically normal HIV-seropositive subjects had reduced numbers of epidermal fibers, suggesting a subclinical neuropathy. Serial biopsies in one individual demonstrated the evolution of degenerating epidermal fibers after development of zalcitabine-induced sensory neuropathy.
Skin biopsies stained with the sensitive panaxonal marker anti-PGP9.5 demonstrated significant reduction in intraepidermal fibers in sensory neuropathies. This simple and repeatable technique is a reliable method for quantitation of small cutaneous sensory fibers. In addition, skin biopsies may be useful in assessing the course and spatial distribution of involvement in peripheral nerve disease.
采用皮肤打孔活检评估感觉神经病中表皮内神经纤维的缺失情况。
以往对表皮神经纤维的评估受到相对不敏感的染色技术和定量变异性的限制。
对HIV血清阴性对照者、无神经病的HIV血清阳性个体以及感觉神经病患者(包括HIV血清阴性和HIV阳性个体)的足跟和腿部进行皮肤打孔活检。经福尔马林固定后,用抗神经元特异性泛素水解酶PGP9.5的单克隆抗体对50微米的游离漂浮切片进行染色。由一名对取材部位和临床状况不知情的观察者对每位患者至少三个切片中的表皮内纤维数量(每毫米)进行计数。
真皮和表皮神经纤维易于识别和定量。免疫染色技术可靠地显示了与皮肤表面平行的有髓和无髓纤维的真皮丛。在表皮中,无髓纤维在角质形成细胞之间垂直上升至角质层。7名HIV血清阴性对照者小腿远端的表皮内纤维数量(均值±标准误)为17.84±3.03。5名接受去羟肌苷或扎西他滨治疗且伴有感觉神经病的HIV感染患者(1.07±0.40)以及8名患有感觉神经病的HIV血清阴性患者(3.1±3.1)的表皮纤维数量显著减少(p = 0.01)。5名神经功能正常的HIV血清阳性受试者中有4名表皮纤维数量减少,提示存在亚临床神经病。对一名个体进行的系列活检显示,扎西他滨诱导的感觉神经病发生后,退化的表皮纤维不断演变。
用敏感的全轴突标记物抗PGP9.5染色的皮肤活检显示,感觉神经病中表皮内纤维显著减少。这种简单且可重复的技术是定量小皮肤感觉纤维的可靠方法。此外,皮肤活检可能有助于评估周围神经疾病的病程和受累的空间分布。